NME1 and non-small cell lung carcinoma: We found that reduced NM23 expression was significantly correlated to higher NSCLC risk, higher TNM staging, poorer differentiation degree, positive lymphatic metastasis, LUAD, and poorer 5-year OS rate in NSCLC patients.